A carregar...
Publicação
Selecting the ideal candidate for Anti-TNF discontinuation in Crohn’s Disease, dream or reality?
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 100.83 KB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
The topic of anti-TNF therapy discontinuation for patients with inflammatory bowel disease in long-term remission is of significance for both clinicians and patients, due to safety concerns, adverse effects, and cost. In the current pandemic era, it has regained renewed attention. However, disease relapse has been reported to occur in roughly 50% of patients, highlighting the need for the development of biomarkers that could help in selecting the best candidates for successful stopping.
Descrição
© 2021 by the AGA Institute
Palavras-chave
Contexto Educativo
Citação
Gastroenterology. 2021 Jul;161(1):353-355
Editora
Elsevier